aspsirna0392 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna0392
siRNA Name: siR206H_A9(U14)_3++
Gene:Activin A receptor type I (ACVR1)
Disease:Fibrodysplasia Ossificans Progressiva (FOP)
Wild allele/target (5'->3'): AGUGGCUCACCAGAUUACA
Mutant allele/target (5'->3'):AGUGGCUCACCAGUUUACACUU
Target Mutation: c.617G>A,p.Arg206His
Wild siRNA (As strand):UCACCGAGUGGUCUAAUGU
ASP-siRNA (As strand):UCACCGAGUGGUCAAAUGU
Mismatch position in siRNA: U11C,A6U
Mutant allele (5'->3'): AGUGGCUCACCAGUUUACACUU
ASP-siRNA (As strand):UCACCGAGUGGUCAAAUGU
ASP-siRNA efficacy for mutant allele:NA
Wild allele (5'->3'): AGUGGCUCACCAGAUUACA
ASP-siRNA (As strand):UCACCGAGUGGUCAAAUGU
ASP-siRNA efficacy for wild allele:13
Percentage discrimination for ASP-siRNA:NA
Wild allele (5'->3'): AGUGGCUCACCAGAUUACA
Wild siRNA (As strand):UCACCGAGUGGUCUAAUGU
Wild sirna efficacy for wild allele:69
Wild allele (5'->3'): AGUGGCUCACCAGAUUACA
ASP-siRNA (As strand):UCACCGAGUGGUCAAAUGU
Wild sirna efficacy for mutant allele:38
Percentage discrimination for wild siRNA:31
Concentration:20nM
Orientation:Double strand
Mismatch in:siRNA
UniProt ID: Q06900
Target sequence: AAGAACAGTGGCTCGCCAGATTACACTGT
Genbank Accesion: NM_001105.4
Cell-line: HeLa
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Sigma-aldrich
Post-transfection duration: 24 hours
OMID ID: 135100
KEGG disease ID:H00430
Reference:22130450

.
.
.
.
.
.
.
.
.
.
.

.

.

.